Menu
Back to User profile » Dr Nathan Wall
Papers published by Dr Nathan Wall:
Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment
Kabagwira J, Fuller RN, Vallejos PA, Sugiono CS, Andrianarijaona VM, Chism JB, O'Leary MP, Caba Molina D, Langridge W, Senthil M, Wall NR
OncoTargets and Therapy 2024, 17:63-78
Published Date: 30 January 2024
Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine
Fuller RN, Kabagwira J, Vallejos PA, Folkerts AD, Wall NR
OncoTargets and Therapy 2022, 15:1147-1160
Published Date: 10 October 2022
Uptake of lymphoma-derived exosomes by peripheral blood leukocytes
Ferguson Bennit HR, Gonda A, Oppegard LJ, Chi DP, Khan S, Wall NR
Blood and Lymphatic Cancer: Targets and Therapy 2017, 7:9-23
Published Date: 28 February 2017
Localization and upregulation of survivin in cancer health disparities: a clinical perspective
Khan S, Ferguson Bennit H, Asuncion Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE, Ashok A, Wall NR
Biologics: Targets and Therapy 2015, 9:57-67
Published Date: 9 July 2015
Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase
Asuncion Valenzuela MM, Castro I, Gonda A, Diaz Osterman CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW, Wall NR
OncoTargets and Therapy 2015, 8:495-507
Published Date: 26 February 2015
Survivin-T34A: molecular mechanism and therapeutic potential
Jonathan R Aspe, Nathan R Wall
OncoTargets and Therapy 2010, 3:247-254
Published Date: 6 December 2010
Dynamic changes to survivin subcellular localization are initiated by DNA damage
Maritess Gay Asumen, Tochukwu V Ifeacho, Luke Cockerham, et al
OncoTargets and Therapy 2010, 3:129-137
Published Date: 1 July 2010